Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs

Patent No. EP3359670 (titled "Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs") was filed by Moderna on Oct 5, 2016. The application was issued on Feb 14, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WITHERS & ROGERSFeb 12, 2021TOMBLING

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3359670

MODERNA
Application Number
EP16782372A
Filing Date
Oct 5, 2016
Status
Patent Maintained As Amended
Jan 12, 2024
Publication Date
Feb 14, 2024